Back to GetFilings.com





SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549



FORM 10-Q


     (MARK ONE)

[X]      QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2003 or


[  ]      TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE TRANSITION PERIOD FROM ___________ TO _____________

Commission file number 0-12254

SCIENTIFIC TECHNOLOGIES INCORPORATED
(Exact name of registrant as specified in its charter)

 
Oregon
77-0170363
  (State or Other Jurisdiction of Incorporation or Organization) 
(I.R.S. Employer Identification Number)

6550 Dumbarton Circle
Fremont, CA    94555

(Address of principal executive offices including zip code)

(510) 608-3400
(Registrant's telephone number, including area code)



Check whether the issuer (1) has filed all reports required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file reports), and (2) has been subject to such filing requirements for the past 90 days.    YES [X] NO [   ],

Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of Act). Yes [  ]    NO [X]

Common stock outstanding as of July 31, 2003 was 9,700,672 shares.





SCIENTIFIC TECHNOLOGIES INCORPORATED
Quarter Ended June 30, 2003
INDEX

PART I. Financial Information Page No.
     
Item 1. Financial Statements (unaudited):
 
     
           Condensed Consolidated Balance Sheets as of
           June 30, 2003 and December 31, 2002
**
     
           Condensed Consolidated Statements of Operations for the
           Three and Six Months ended June 30, 2003 and 2002
**
     
           Condensed Consolidated Statements of Cash Flows for the
           Six Months ended June 30, 2003 and 2002
**
     
           Notes to Condensed Consolidated Financial Statements
**
     
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
**
     
Item 3. Quantitative and Qualitative Disclosures About Market Risk
**
     
Item 4. Controls and Procedures
**
     
PART II. Other Information
 
     
Item 4. Submission of Matters to a Vote of Security Holders
**
     
Item 6. Exhibits and Reports on Form 8-K
**
     
Signatures
**







PART 1 - FINANCIAL INFORMATION

ITEM 1 - FINANCIAL STATEMENTS








SCIENTIFIC TECHNOLOGIES INCORPORATED

CONDENSED CONSOLIDATED BALANCE SHEET

(Unaudited, in thousands, except for per share data)

Assets

Jun. 30, 2003

Dec. 31, 2002

Current assets:

 

 

Cash and cash equivalents

$ 2,140

$ 2,620

Accounts receivable, net

7,864

7,636

Inventories

9,816

8,719

Deferred income taxes

2,380

2,380

Receivable from Parent

759

384

Other current assets

500

527

Total current assets

23,459

22,266

 

 

 

Property and equipment, net

3,999

3,725

Goodwill and other intangible assets

10,960

11,593

Other assets

308

308

Total assets

$38,726

$37,892

Liabilities and Shareholders' Equity

Current liabilities:

 

Accounts payable

$ 3,316

$ 2,942

Accrued expenses

2,952

2,836

Current portion of capital lease with Parent

68

60

Total current liabilities

6,336

5,838

 

 

 

Capital lease with Parent

198

240

Deferred income taxes

2,064

2,064

Total liabilities

8,598

8,142

Shareholders' equity:

Common stock; $.001 par value; 100,000 shares
authorized; 9,701 and 9,687 shares issued and
outstanding

10

10

Capital in excess of par value

5,761

5,681

Retained earnings

24,357

24,059

Total shareholders' equity

30,128

29,750

Total liabilities and shareholders' equity

$38,726

$37,892

The accompanying notes are an integral part of these financial statements.








SCIENTIFIC TECHNOLOGIES INCORPORATED

CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS

(Unaudited, in thousands, except per share data)

 

For the three months ended

 

Jun. 30, 2003

Jun. 30, 2002

 

 

 

Sales

$14,273

$12,829

 

 

 

Cost of sales

8,127

7,223

 

 

 

Gross profit

6,146

5,606

 

 

 

Operating expenses:

 

 

Selling, general and administrative

4,504

3,952

Research and development

1,155

1,241

Amortization of intangible assets

170

190

Total operating expenses

5,829

5,383

 

 

 

Income from operations

317

223

 

 

 

Interest and other income, net

18

7

 

 

 

Income before income taxes

335

230

 

 

 

Provision for income taxes

127

87

 

 

 

Net income

$ 208

$ 143

 

 

 

Net income per share:

 

 

Basic and diluted

$ 0.02

$ 0.01

 

 

 

Shares used to compute net income per share:

Basic

Diluted

9,700

9,723

9,675

9,679

 

 

 

The accompanying notes are an integral part of these financial statements.








SCIENTIFIC TECHNOLOGIES INCORPORATED

CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS

(Unaudited, in thousands, except per share data)

 

For the six months ended

 

Jun. 30, 2003

Jun. 30, 2002

 

 

 

Sales

$27,233

$24,058

 

 

 

Cost of sales

15,541

13,747

 

 

 

Gross profit

11,692

10,311

 

 

 

Operating expenses:

 

 

Selling, general and administrative

8,588

7,581

Research and development

2,328

2,490

Amortization of intangible assets

335

353

Total operating expenses

11,251

10,424

 

 

 

Income (loss) from operations

441

(113)

 

 

 

Interest and other income, net

39

9

 

 

 

Income (loss) before income taxes

480

(104)

 

 

 

Provision for (benefit from) income taxes

182

(40)

 

 

 

Net income (loss)

$ 298

$ (64)

 

 

 

Net income (loss) per share:

 

 

Basic and diluted

$ 0.03

$ (0.01)

 

 

 

Shares used to compute net income per share:

Basic

Diluted

9,695

9,729

9,672

9,672

 

 

 

The accompanying notes are an integral part of these financial statements.








SCIENTIFIC TECHNOLOGIES INCORPORATED

CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS

(Unaudited, in thousands)

 

For the six months ended

 

Jun. 30, 2003

Jun. 30, 2002

 

 

 

Cash flows from operating activities

 

 

Net income (loss)

$ 298

$ (64)

Adjustments to reconcile net income (loss) to cash

 

 

provided by operating activities:

 

 

Depreciation and amortization

1,327

1,317

Changes in assets and liabilities:

 

 

Accounts receivable

(228)

(803)

Inventories

(1,097)

509

Receivable from Parent

(375)

--

Other assets, current and non-current

27

(486)

Accounts payable

374

150

Accrued expenses

116

400

Cash flows provided by operating activities

442

1,023

 

 

 

Cash flows from investing activities

 

 

Purchase of property and equipment

(968)

(794)

Cash flows used in investing activities

(968)

(794)

provided by

Cash flows from financing activities

 

 

Repayment of capital lease with Parent

(34)

--

Issuance of common stock

80

20

Cash flows provided by financing activities

46

20

Change in cash and cash equivalents

(480)

249

 

 

 

Cash and cash equivalents at beginning of period

2,620

1,033

Cash and cash equivalents at end of period

$ 2,140

$ 1,282

Supplemental disclosure of cash flow information:

Cash paid to (received from) Parent for income taxes

$ 182

$ (40)

The accompanying notes are an integral part of these financial statements.








SCIENTIFIC TECHNOLOGIES INCORPORATED

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

1. INTERIM FINANCIAL STATEMENTS

The accompanying condensed consolidated financial statements for the three and six months ended June 30, 2003 and 2002 are unaudited and have been prepared in accordance with generally accepted accounting principles in the United States of America and in accordance with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles in the United States of America for complete financial statements. In the opinion of management, the unaudited condensed consolidated financial statements reflect all adjustments, consisting only of normal recurring adjustments, considered necessary to present fairly the financial position, results of operations and cash flows of Scientific Technologies Inc. (the "Company") and its subsidiaries for all periods presented.

To prepare these condensed consolidated financial statements in conformity with generally accepted accounting principles, management of the Company has made a number of estimates and assumptions relating to the reporting of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and revenue and expenses during the reporting period. Actual results could differ from those estimates.

The results of operations are not necessarily indicative of the results to be expected in the future or for the full fiscal year. It is recommended that these condensed consolidated financial statements be read in conjunction with the Company's audited consolidated financial statements and the notes thereto included in its 2002 Annual Report on Form 10-K.

Recent Accounting Pronouncements

In November 2002, the Emerging Issues Task Force, or EITF, reached a consensus on Issue No. 00-21, "Revenue Arrangements with Multiple Deliverables." EITF Issue No. 00-21 provides guidance on how to account for arrangements that involve the delivery or performance of multiple products, services and/or rights to use assets. The provisions of EITF Issue No. 00-21 will apply to revenue arrangements entered into in fiscal periods beginning after June 15, 2003. The Company believes that the adoption of this standard will have no material impact on its financial statements.

In January 2003, the FASB issued Interpretation No. 46 ("FIN No. 46") "Consolidation of Variable Interest Entities." Until this interpretation, a company generally included another entity in its consolidated financial statements only if it controlled the entity through voting interests. FIN No. 46 requires a variable interest entity to be consolidated by a company if that company is subject to a majority of the risk of loss from the variable interest entity's activities or entitled to receive a majority of the entity's residual returns. The Company does not expect its adoption of FIN 46 to have a material impact on its consolidation financial statements.

In May 2003, the Financial Accounting Standards Board issued Statement of Financial Accounting Standards No. 150, "Accounting for Certain Financial Instruments with Characteristics of both Liabilities and Equity". SFAS No. 150 establishes standards for how an issuer classifies and measures certain financial instruments with characteristics of both liabilities and equity. SFAS No. 150 requires that an issuer classify a financial instrument that is within its scope as a liability (or an asset in some circumstances). SFAS No. 150 is effective for financial instruments entered into or modified after May 31, 2003, and otherwise is effective at the beginning of the first interim period beginning after June 15, 2003. The Company believes that the adoption of this standard will have no material impact on its financial statements.

2. STOCK-BASED COMPENSATION

Statement of Financial Accounting Standards No. 148, issued in December 2002, amends SFAS No. 123 to require that disclosures of the pro forma effect of using the fair value method of accounting for stock-based employee compensation be presented on a quarterly basis and displayed more prominently and in a tabular format. The following table sets forth the effect on the Company's net income (loss) and net income (loss) per share as if the Company had recorded compensation costs based on the estimated grant date fair value as defined by SFAS No. 123 for its stock-based awards (in thousands, except per share amounts).

Six Months Ended June 30,

2003

2002

Net income (loss), as reported

$ 298

$ (64)

Add: Stock-based employee compensation expense
included in reported net income (loss)

-

 

-

Deduct: Stock-based employee compensation expense
determined under fair value based method, net of tax

45

41

Pro forma net income (loss)

$ 253

$(105)

Net income (loss) per share - basic and diluted:

As reported

$ 0.03

$ (0.01)

Pro forma

$ 0.03

$ (0.01)

3. INVENTORIES

Inventories consist of the following (In thousands):

 

Jun. 30, 2003

Dec. 31, 2002

Raw materials

$4,852

$4,501

Subassemblies

1,101

1,016

Work in process

1,605

1,043

Finished goods

2,258

2,159

 

$9,816

$8,719

4. NET INCOME (LOSS) PER SHARE

A reconciliation of the numerators and denominators used to compute basic and diluted net income (loss) per common share is provided below.

 

(In thousands)

 

 

Income (loss)

Shares

(Per share) Amount

Three months ended June 30, 2003

 

 

 

Basic earnings per share calculation

$ 208


9,700

$ 0.02


Effect of dilutive securities
   Stock options

 

  23


 

Diluted earnings per share calculation

$ 208


9,723


$ 0.02


Three months ended June 30, 2002

 

 

 

Basic earnings per share calculation

$ 143)


9,675

$ 0.01


Effect of dilutive securities
   Stock options

 

  4


 

Diluted earnings per share calculation

$ 143


9,679


$ 0.01


Six months ended June 30, 2003

 

 

 

Basic earnings per share calculation

$ 298


9,695

$ 0.03


Effect of dilutive securities
   Stock options

 

  34


 

Diluted earnings per share calculation

$ 298


9,729


$ 0.03


Six months ended June 30, 2002

 

 

 

Basic and diluted loss per share calculation

$ (64)


9,672


$ (0.01)


5. COMPREHENSIVE INCOME (LOSS)

For the three and six months ended June 30, 2003 and 2002, there is no significant difference between net income (loss) and comprehensive income (loss).

6. SEGMENT REPORTING AND OTHER INFORMATION

Financial information for each product group is as follows: (in thousands)

Three months ended

June 30,

Safety Products

2003

2002

Sales

$11,853

$10,770

Group operating profit

793

512

Automation Products

Sales

$ 2,420

$ 2,059

Group operating loss

(476)

(289)

Six months ended

June 30,

Safety Products

2003

2002

Sales

$22,931

$20,203

Group operating profit

1,354

611

Automation Products

Sales

$ 4,302

$ 3,855

Group operating loss

(913)

(724)

At

Jun. 30

Dec. 31

Total Assets

2003

2002

Safety Products

$30,851

$28,646

Automation Products

7,875

9,246

Total

$ 38,726

$ 37,892

The Company operates principally in the United States. The Company's operations in Germany are less than 10% of total operations. Sales to foreign customers represented less than 10% of total sales in the three and six months ended June 30, 2003 and 2002.

7. COMMITMENT AND CONTINGENCIES

The Company offers warranties on certain products and records a liability for the estimated future costs associated with warranty claims, which is based upon historical experience and the Company's estimate of the level of future costs. A reconciliation of the changes in the Company's warranty liability follows (in thousands):

For the three months ended June 30, 2003

Warranty accrual at April 1, 2003

$241

Accruals for warranties issued

40

Expenses incurred

(53)

Warranty accrual at June 30, 2003

$228

For the six months ended June 30, 2003

Warranty accrual at January 1, 2003

$241

Accruals for warranties issued

96

Expenses incurred

(109)

Warranty accrual at June 30, 2003

$228

As permitted under Oregon law the Company has agreements whereby the Company indemnifies its officers and directors for certain events or occurrences while the officer or director is, or was serving at the Company's request in such capacity. The indemnification term is for the period that the officer or director is serving in such capacity or is subject to any possible claim or action by reason of the fact that the Indemnitee was serving in that capacity. The maximum potential amount of future payments by the Company could be unlimited; however the Company has a director and officer insurance policy that limits the Company's exposure and enables the Company to recover a portion of any future amounts paid. As a result of the insurance policy coverage, the Company believes that the estimated fair value of these agreements is minimal.

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

This interim report on Form 10-Q contains trend analysis and other forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such statements include expectations, beliefs, intentions or strategies regarding future operating results, future expenditures, future cash requirements, future impact of the relocation of the PSI-Tronix division and future industry conditions that involve risks and uncertainties. The Company's actual results could differ materially from those projected in such forward-looking statements as a result of many factors, including, without limitation, those set forth under this section, the section entitled "Business Factors" below and elsewhere in this report on Form 10-Q.

Results of Operations

(Amounts in thousands, except percentages)

Scientific Technologies Incorporated designs, manufactures and distributes automation safeguarding and specialty sensor products for the industrial control market. The Company's products include safety light guards, profiling scanners, factory automation sensors, controls, components, microcomputers, fiber optics, power monitoring devices, safety mats, pressure, displacement and velocity transducers, digital pressure gauges and comparators and other electronic equipment supplied to industrial automation, commercial and defense customers.

Sales for the three months ended June 30, 2003 increased 11% to $14,273 from $12,829 in the comparable period in 2002. Sales for the six months ended June 30, 2003 increased 13% to $27,233 from $24,058 in the same period in 2002. The Safety Products Group sales grew 10% and 14% for the three and six months ended June 30, 2003, while the Automation Products Group sales grew 18% and 12% % for the three and six months ended June 30, 2003, compared to the same periods in 2002.

Gross margin as a percentage of sales declined to 43% for the three months ended June 30, 2003 compared to 44% for the comparable period in 2002. Year to date gross margin remained constant at 43% of sales in both periods. During the second quarter of 2003 we experienced a change in the mix of products sold by both groups to products bearing a higher relative cost of sales. In addition, service revenue from our Dunn Sales operations, which carries a lower gross margin than our other products, represented a larger proportionate share of our total sales in 2003 compared to 2002.

Selling, general and administrative expenses for the three and six months ended June 30, 2003 increased 14% and 13% to $4,504 and $8,588 from $3,952 and $7,581 in the same periods of 2002. This was the result of increased costs associated with our increased revenue, costs related to the relocation and combining of our Tulare, California operations with our current facility in Logan, Utah and increased premiums on our business insurance. As a percentage of sales for the three and six month periods ended June 30, 2003, selling, general and administrative expenses were constant at 32% compared to 31% and 32% for the comparable 2002 periods, respectively.

Research and development expenses for the second quarter and the first six months of 2003 declined to $1,155 and $2,328 from $1,241 and $2,490 in the comparable 2002 periods, respectively. This was due primarily to reduced consulting expenses. As a percentage of sales for the three and six months ended June 30, 2003, research and development expenses were 8% and 9%, respectively, compared to 10% for the same periods of 2002.

Intercompany transactions between our parent company and us include charges to our parent for management services provided by us, other cash transfers and expenses paid on behalf of our parent.

Liquidity and Capital Resources

At June 30, 2003, our working capital increased 4% to $17,123 compared to $16,428 reported at December 31, 2002.

Available bank borrowings were $6,100, all of which were unused at June 30, 2003. We believe that cash from operations, together with cash resources and available bank borrowings, will be sufficient to fund working capital requirements for the next twelve months.

Critical Accounting Policies

A discussion of our critical accounting policies is set forth in our 2002 Annual Report on Form 10-K, which was filed with the Securities and Exchange Commission on March 3l, 2003. There were no material changes in any of our critical accounting estimates or judgments during the first six months of 2003.

Business Factors

Because of the variety of factors and uncertainties affecting our operating results, past financial performance and historic trends may not be a reliable indicator of future performance. These factors, as well as other factors affecting our operating performance, may result in significant volatility in our common stock price. Among the factors which could affect our future business, financial condition or operating results are the following:

Our operating results may fluctuate.

We have experienced fluctuations in annual and quarterly operating results and anticipate that these fluctuations will continue. These fluctuations are caused by a number of factors, including the level and timing of customer orders, fluctuations in purchases of complementary third party products with which our products are sold, the mix of products sold and the timing of operating expenditures. Our operating results have been, and could continue to be negatively impacted by generally adverse economic conditions throughout the high technology sector. In particular, the relocation of our PSI-Tronix subsidiary may prove to be more costly than anticipated or may not result in the expected benefits, and its continuing decreases in sales due to the current market conditions in the semiconductor industry could negatively effect our operating results.

The seasonality inherent in our business could cause our operating results to fluctuate.

The industrial manufacturing equipment industry in which we compete has historically been subject to seasonality. This is also true with respect to European markets in which we compete where business activity declines due to vacations taken in the summer months. This seasonality, combined with other factors such as the variability in our operating results described above, renders quarter-to-quarter comparisons of our results of operations unreliable as indicators of our overall performance.

The market for our products is highly competitive.

The market for industrial sensors is highly competitive. Many competitors have substantially greater name recognition and technical, marketing and financial resources than we have. Competitive pressures could reduce market acceptance of our products and result in price reductions, decreased revenues and increases in expenses.

Our business could suffer if we do not respond to technological change and new product development demands of our customers.

The market for our products is characterized by changing technology, evolving industry standards, changes in customer needs and new product introductions. Our future success will depend on our ability to enhance current products, develop new products and respond to emerging industry standards, all on a timely and cost-effective basis. The introduction of new products also requires that we manage the transition from older products in order to minimize disruption of customer orders, avoid excessive levels of older product inventories and ensure that adequate supplies of new products can be delivered to meet customer demands.

Our sales are dependent on indirect distribution channels.

A majority of our sales are through third party distributors, system integrators and original equipment manufacturers. These resellers are not required to offer our products exclusively. We cannot be assured that a reseller will continue to offer our products. In addition many of our resellers are privately owned firms which may not be well capitalized. If our ability to sell products through these third parties is impaired, our results of operations would likely suffer.

Our international sales are subject to risks.

Our international sales may be disrupted by currency fluctuations or other events beyond our control, including political or regulatory changes. If our international sales were disrupted for any reason, our revenue levels would decline.

Our business could suffer if we are unable to protect and enforce our intellectual property rights.

We rely on a combination of patent, trademark and trade secret laws and contractual restrictions to establish and protect proprietary rights in our products and services. There can be no assurance that our patents, trademarks, or contractual arrangements or other steps taken by us to protect our intellectual property will prove sufficient to prevent misappropriation of our technology or defer independent third party development of similar technologies. Moreover, there can be no assurance that the technology licenses granted to us from our parent company will continue to be available. The loss of any of our proprietary technology could require us to obtain technology of lower quality or performance standards or at greater cost, which could materially adversely affect our business, results of operations and financial condition. Furthermore, the laws of certain foreign countries may

not protect our products, services or intellectual property rights to the same extent as do the laws of the United States.

Item 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

For qualitative and quantitative disclosures about market risks affecting us, see Item 7A "Quantitative Disclosure About Market Risk" of our Annual Report on Form 10-K for the year ended December 31, 2002. Our exposure to market risk has not changed materially since December 31, 2002.

Item 4. CONTROLS AND PROCEDURES.

(a) As of the end of the period covered by this quarterly report on Form 10-Q, our management evaluated, under the supervision and with the participation of our officers performing the functions of Chief Executive Officer and Chief Financial Officer, the effectiveness of our disclosure controls and procedures. Based on this evaluation, our officers performing the functions of Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures are effective to ensure that information we are required to disclose in reports that we file or submit under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in Securities and Exchange Commission rules and forms.

(b) There was no change in our internal control over financial reporting that occurred during the period covered by this quarterly report on Form 10-Q that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

PART II - OTHER INFORMATION

Items 1 - 3, and 5 are not applicable for this reporting period.

Item 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

At the Annual Meeting of shareholders held on May 22, 2003, the shareholders re-elected the following to the Board of Directors, Anthony R. Lazzara: 9,503,440 shares for, Joseph J. Lazzara: 9,503,240 shares for, James A. Lazzara: 9,502,715 shares for, James A. Ashford: 9,528,070 shares for, Carl H. Frei: 9,539,339 shares for, Bernard L. Ploshay: 9,525,870 shares for and Richard S. Baldwinson: 9,539,339 shares for.

Item 6. EXHIBITS AND REPORTS ON FORM 8-K.

(a) The following documents are filed as a part of this Report:

Exhibit 3.1 -

Articles of Incorporation, as amended, are incorporated by reference to the Registrant's Form 10-K for the year ended December 31, 1988, Exhibit 3.1.

Exhibit 3.3 -

By-Laws are incorporated by reference to the Registrant's Form 10-K for the year ended December 31, 1985, Exhibit 3.

Exhibit 4.1 -

1997 Employee Stock Purchase Plan is incorporated by reference to the Registrant's Registration Statement on Form S-8 dated October 2, 1998.

Exhibit 4.2 -

1997 Stock Plan is incorporated by reference to the Registrant's Registration Statement on Form S-8 dated October 2, 1998.

Exhibit 24.1 -

Power of Attorney is incorporated by reference to the Registrant's Form 10-K for the year ended December 31, 2002, Exhibit 24.1.

Exhibit 31

Section 302 Certification of Chief Executive and Chief Financial Officers

Exhibit 32

Section 906 Certification of Chief Executive and Chief Financial Officers

(b)    A Report on Form 8-K was filed on May 9, 2003 furnishing the First Quarter Earnings Release of Scientific Technologies Incorporated to the Securities and Exchange Commission.








SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

SCIENTIFIC TECHNOLOGIES INCORPORATED
            Registrant

Date: August 13, 2003

 

/s/Joseph J. Lazzara
Joseph J. Lazzara
President and Chief Executive Officer
(Principal Executive Officer)

 

Date: August 13, 2003

 

/s/ Richard O. Faria
Richard O. Faria
Vice-President and Chief Financial Officer
(Principal Financial Officer)